This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In a double-blind study, 30 children at Rhode Island Hospital with moderate to severe acute asthma exacerbations and peak expiratory flow rates (PEFR) < 70% predicted after 3 treatments with nebulized albuterol or ipratropium bromide (or both) were randomized to receive either 40 mg/kg (maximum dose 2 gm) of magnesium sulfate intravenously over 20 minutes (16 patients, 11 male, mean age 10.9 years) or normal saline (14 patients, 7 male, mean age 12 years). The children were given intravenous steroids if they had not already …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Purchase access
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.